Enabling wider adoption of generic medicines demands three pillars of reform: changing prescription habits of doctors, ...

Sam Pharmaceutical Limited has injected N6.2b to boost local drug production capacity, targeted at reducing the country's reliance on imported medicines.The boost in the drug production was driven by ...

Steel Power has quickly emerged as one of the most talked-about male wellness supplements of 2026, attracting widespread ...

Explore the challenges and strategies for achieving medical cannabis GMP compliance, crucial for product consistency and ...

Explore key questions on contamination control strategies to support regulatory compliance and risk management in ...

New solutions include customized reagents that scale from bench to clinical trials, industrialized lentiviral vector ...

The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for ...

HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, ...

Regulatory approval is a major milestone in the drug development process, but it is not the final chapter in the journey.

Under the terms of the agreement, Emergent will provide end-to-end development and manufacturing services to SAB BIO that are compliant with current good manufacturing practices. These services will ...

Emergent BioSolutions Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (Nasdaq: SABS, SAB BIO) to support the process ...

FDA inspectors warned UCSF radiopharmaceutical facility that losing environmental control could pose a serious hazard to ...